reverse remodeling.
48
Cathepsins are lysosomal proteases contributing to autophagic degradation of 49 cellular substrates (30) . They are composed of 11 members (cathepsin B, C, F, H, K, L,
50
O, S, V, X and W), most of which are ubiquitously expressed in living organisms (30) .
51
Cathepsins play a role in a number of signaling pathways and appear to be associated 52 with several diseases, including neurological disorders (23) , cancers (28) and 53 cardiomyopathies (18). Increased cathepsin gene expression was reported in conditions 54 of cardiac stress, remodeling and dysfunction. Cathepsin S and K were found increased 55 in pressure overload-induced myocardium of rodents and in humans with hypertension-56 induced heart failure (2). Cathepsin D was found to be elevated in the plasma of 57 patients after myocardial infarction (MI) (21).
58
Validation for the important roles of cathepsins in the heart and during cardiac 59 pathogenesis came recently from studies of cathepsin K, L, S and D knockout mice.
Loss of cathepsin K alleviates both pressure overload-induced and high fat diet-induced 61 cardiac hypertrophy, likely through the inhibition of mTOR and ERK pathways (13; 14).
62
On the contrary, several other cathepsins were found to be cardioprotective. Loss of 63 cathepsin L promoted cardiac hypertrophy upon stress, which was associated with 64 accumulation of protein substrates such as α-actinin, myosin, connexin-43 and H-65 cadherin (27). Moreover, cathepsin S seems to play a role in cardiac maintenance since 66 its deletion exacerbated AngII-induced cardiac inflammation (22).
67
While the functions of these cathepsins, specifically cathepsin L, for the heart are Recently, CTSB expression was found to be induced in H9c2 cells, a myoblastic 80 cell line derived from rat heart, after doxorubicin treatment (1). CTSB upregulation was 81 closely associated with NFκB protein levels, although an exact mechanism for the 82 regulation, and its influence on NFκB signaling is unknown. CTSB may also play a role 83 during post-MI remodeling (29), and in patients with dilated cardiomyopathy (7).
84
Although the molecular mechanism remains elusive, data from the doxorubicin-induced 85 cardiotoxicity and the MI models, as well as dilated cardiomyopathy patients, suggested 
127
The authors then provided some insight into the signaling pathways that may be 
131
Knockout of CTSB reduced the observed increases in TNFα, p-ASK1, p-JNK and p-c-
132
Jun, but had no effect on phosphorylation of p38, ERK1/2 and Akt. Corresponding in 
